FDA Safety Information and Adverse Event Reporting
Zyprexa Relprevv (Olanzapine Pamoate): Drug Safety Communication - FDA Investigating Two Deaths Following Injection
Endologix, Inc. AFX Introducer System: Class 1 Recall - Reports Of Dilator Breaking During Procedures
Cybersecurity for Medical Devices and Hospital Networks: FDA Safety Communication
May 2013
Main Street Family Pharmacy in Tennessee: FDA Alerts Health Care Providers of Adverse Reactions Associated with Steroid Injections
Warfarin 2 mg Tablets by Zydus Pharmaceuticals USA Inc.: Recall - Due to Oversized Tablets
Symbios GOPump and GOBlock Kits: Class 1 Recall - Potential for Excessive High Flow Rates
Bethel Nutritional Consulting, Inc. Bethel 30: Recall: Undeclared Drug Ingredient.
Vecuronium Bromide For Injection by Sagent Pharmaceuticals, Inc.: Recall - Elevated Impurity Result Detected
Nephron Pharmaceuticals Corp. EZ Breathe Atomizer: Class 1 Recall - Washer Could Become Dislodged
Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance
Magnesium Sulfate: Drug Safety Communication - Recommendation Against Prolonged Use in Pre-term Labor
Magnesium Sulfate Injection by Fresenius Kabi USA: Recall - Glass Particles in Vials
Cook Medical, Inc Zilver PTX Drug-Eluting Peripheral Stent: Class 1 Recall - Complaints of Delivery System Tip Separation
Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials
Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result
All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance
Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses
Atriphen dietary supplement (Xymogen brand): Recall - Potential Allergic Reaction Due to Milk and Soy

FDA Safety Information and Adverse Event Reporting

Description

June 13, 2013
MedWatch May 2013 drug safety labeling changes
Web Link

FDA Safety Information and Adverse Event Reporting is a sample topic found in Davis's Drug Guide.

To find other Davis's Drug Guide topics please log in or purchase a subscription.

Content Manager

Related Content

About